Silverarc Capital Management’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-54,075
| Closed | -$260K | – | 88 |
|
|
2023
Q3 | $260K | Hold |
54,075
| – | – | 0.08% | 64 |
|
|
2023
Q2 | $210K | Hold |
54,075
| – | – | 0.07% | 71 |
|
|
2023
Q1 | $136K | Buy |
54,075
+27,199
| +101% | +$68.3K | 0.06% | 65 |
|
|
2022
Q4 | $48.9K | Sell |
26,876
-586
| -2% | -$1.07K | 0.01% | 79 |
|
|
2022
Q3 | $187K | Buy |
27,462
+1,425
| +5% | +$9.7K | 0.06% | 65 |
|
|
2022
Q2 | $281K | Sell |
26,037
-22,737
| -47% | -$245K | 0.09% | 53 |
|
|
2022
Q1 | $1.09K | Buy |
48,774
+522
| +1% | +$12 | 0.45% | 48 |
|
|
2021
Q4 | $1.36M | Buy |
48,252
+16,756
| +53% | +$473K | 0.55% | 48 |
|
|
2021
Q3 | $2.05M | Sell |
31,496
-15,692
| -33% | -$1.02M | 1.16% | 27 |
|
|
2021
Q2 | $3.76K | Buy |
+47,188
| New | +$3.76K | 1.68% | 17 |
|